Articles related to CLINICAL TRIALS

Discover how Roswell Park’s phase 2 clinical trials are exploring the potential of propranolol to enhance the efficacy of immunotherapies in treating esophageal cancer. This could represent a significant shift in treatment protocols.

New data from the FLAURA2 trial suggests a promising but complex treatment landscape for EGFR-mutated advanced NSCLC. Physicians should weigh the significant PFS benefits against the increased risk of adverse events before considering this combination as a first-line treatment option.

Discover how sacituzumab govitecan is setting a new standard in the treatment of HR+, HER2- metastatic breast cancer, offering improved survival rates and lower risks of progression.

The recent phase 2 study on atezolizumab shows promising results in inducing sustained responses in advanced ASPS patients.

Explore the clinical insights into lumateperone, a second-generation antipsychotic showing promise in treating schizophrenia, and learn how understanding effect sizes can guide your treatment decisions.

Discover how real-world data on 177Lu PSMA validates its efficacy in mCRPC treatment, providing actionable early markers for therapeutic response. Learn how these findings can enhance your clinical decision-making.